
Puneeth Rajkumar's Death Linked To Covishield Side Effects? Actor's Old Vaccine Shot Tweet Sparks Buzz
Puneeth Rajkumar didn't just get vaccinated against COVID-19; he also took on an active role in advocating for its importance. He enthusiastically engaged in several health department initiatives aimed at educating the public on essential measures to tackle the pandemic. Fans are now sharing videos showcasing his commitment to promoting vaccination.
Puneeth Rajkumar no more: Check out his last social media post shared few hours ago before his death
Puneeth Rajkumar received his vaccination and shared his experience on social media on April 7, 2021, tweeting, "Got my first dose of vaccination today. If you are 45 years & above ensure you get vaccinated." The tweet rapidly gained momentum among his followers, who retweeted it, causing it to go viral. However, It is not known whether actor Puneeth Rajkumar had received the Covaxin or Covishield vaccine.
How did Puneeth Rajkumar pass away?
On the morning of October 29, 2021, Puneeth experienced chest pain after his routine exercise and was rushed to a local clinic followed by Vikram Hospital, where he tragically passed away. Puneeth Rajkumar was also known for his active participation in public health campaigns promoting COVID-19 safety measures, including vaccination.
However, as there is a discussion about the side effects of Covishield, fans are expressing sadness by linking it to Appu's death.
Karnataka govt ropes in actor Puneeth Rajkumar to spread awareness about COVID
What has AstraZeneca acknowledged regarding the side effects of its vaccine?
AstraZeneca is currently facing a lawsuit in the UK over allegations that its vaccine led to deaths. 51 cases have been filed against the company. In court documents, AstraZeneca has acknowledged that Covishield can, in extremely rare instances, cause Thrombosis with Thrombocytopenia Syndrome (TTS).
Puneeth Rajkumar no more: Kannada star, 46, suffers massive heart attack
While it is a widely accepted scientific consensus that vaccines are crucial in combating the spread of COVID-19 concerns specific to Covishield have focused on thrombosis with thrombocytopenia syndrome (TTS), a condition involving blood clots and low platelet counts. However, it is important to note that such conditions are extremely rare. Health experts and numerous studies have reiterated that the benefits of vaccination greatly outweigh the risks for the vast majority of the population.
Despite these reassurances, the sudden increase in heart attack cases among younger demographics post-pandemic has been alarming. Previously seen primarily in older adults, these incidents have raised questions about possible links to the COVID-19 infection itself or the vaccines.
As this debate continues, it is crucial for public health messages to balance vaccine advocacy with transparent communication regarding potential risks, no matter how rare, to maintain public trust.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Manuka Honey Market Report 2024, Industry Growth, Size, Share, Top Compan...
- Modular Kitchen Market 2024, Industry Growth, Share, Size, Key Players An...
- Acrylamide Production Cost Analysis Report: A Comprehensive Assessment Of...
- Fish Sauce Market 2024, Industry Trends, Growth, Demand And Analysis Repo...
- Australia Foreign Exchange Market Size, Growth, Industry Demand And Forec...
- Cold Pressed Oil Market Trends 2024, Leading Companies Share, Size And Fo...
- Pasta Sauce Market 2024, Industry Growth, Share, Size, Key Players Analys...
Comments
No comment